A phase 2 trial shows that a single dose of psilocybin provides lasting relief from symptoms of depression and anxiety. New results from a clinical trial show that a single dose of psilocybin, a naturally occurring psychedelic compound found in mushrooms, can lead to lasting reductions in depression and anxiety in people with cancer who […]



Summary

A phase 2 clinical trial indicates that a single dose of psilocybin, the psychedelic compound in certain mushrooms, can provide long-lasting relief from depression and anxiety symptoms. This promising result was observed in individuals with cancer, suggesting a potentially significant therapeutic effect. While further research is needed, this study offers compelling evidence for psilocybin’s potential as a treatment for emotional distress associated with serious illnesses.

Read more…

This post is part of “Science and Technology News”, Follow for more…!!!